Life Sciences Technology / Spatial Biology / Biotechnology Research
Strategic Profile
As of July 8, 2025, Akoya Biosciences operates as a subsidiary of Quanterix Corporation, which strengthens its market position and resources. The company is positioned in the high-growth spatial biology market, targeting immuno-oncology and translational research applications with a diverse product portfolio and advanced imaging solutions.
Cyborg Score Rationale
The company generates gross profit of $47.9M but operates with negative operating income of -$46.7M on a TTM basis, indicating profitability challenges despite revenue generation. Recent acquisition by Quanterix provides strategic support, but execution and market adoption remain key metrics to monitor.
Top Insights
Spatial biology is an emerging market with strong biotech and pharma demand for multi-parameter tissue analysis
Acquisition by Quanterix for nearly $364 million validates market positioning and provides capital for growth
Strategic partnerships like exclusive license with NeraCare for melanoma diagnostics expand into clinical diagnostics and personalized medicine
Company has approximately 201 employees across 5 continents